secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adagio Medical Holdings, Inc. (ADGM)
CIK:        0002006986
Form:       8-K
Filed at:   2026-09-23T12:01:31+00:00
Accession:  0001104659-26-109821
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 2.05, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adagio Medical launches strategic alternatives review; cuts 25 of 43 employees
------------------------------------------------------------------------------

- Reducing workforce by 25 of 43 FTEs effective Sept 23, 2026; est. $1.3M in cash costs for severance and benefits.
- Cash, equivalents and marketable securities ~$7.7M as of June 30, 2026 (preliminary unaudited).
- Board initiates formal strategic review; may consider acquisition, merger, business combination; no timetable set.
- Will lower 13% senior secured convertible notes conversion price to 85% of VWAP (5-day) during Sept 23–Oct 31, 2026.
- Continuing to advance PMA application for vCLAS ventricular ablation system.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2006986/000110465926109821/0001104659-26-109821-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2006986/000110465926109821/adgm-20260923x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-109821

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer